Table 3.
Morbidities of newborns included in the study.
| Group 1 | Group 2 | p | |
|---|---|---|---|
| n = 164 | n = 157 | ||
| Mortality, No. (%) | 9 (5.5) | 9 (5.7) | 0.558 |
| NEC stage III, No. (%) | 1 (0.6) | 4 (3.0) | 0.125 |
| BPD, No. (%) | 13 (7.9) | 4 (2.7) | 0.033 * |
| Culture-proven sepsis, No. (%) | 12 (7.4) | 28 (18.7) | 0.002 * |
| Retinopathy of prematurity, No. (%) | 34 (20.9) | 16 (10.5) | 0.009 * |
| Periventricular leukomalacia, No. (%) | 4 (2.5) | 4 (2.9) | 0.552 |
| Intraventricular hemorrhage, No. (%) | 12 (7.4) | 10 (6.7) | 0.493 |
| Patent ductus arteriosus, No. (%) | 39 (23.9) | 35 (23.2) | 0.491 |
| Severe anemia, No. (%) | 43 (26.4) | 41 (27.2) | 0.489 |
| Overall morbidity, No (%) | 51 (31.1) | 62 (40.3) | 0.056 |
Notes. * p < 0.05.